Neogen Chemicals (NEOGEN) Aktienübersicht
Neogen Chemicals Limited beschäftigt sich mit der Herstellung und dem Verkauf von Spezialchemikalien in Indien. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 0/6 |
| Künftiges Wachstum | 5/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 2/6 |
| Dividenden | 0/6 |
NEOGEN Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Neogen Chemicals Limited Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | ₹2,009.80 |
| 52-Wochen-Hoch | ₹2,090.00 |
| 52-Wochen-Tief | ₹966.70 |
| Beta | 0.60 |
| 1 Monat Veränderung | 5.58% |
| 3 Monate Veränderung | 64.98% |
| 1 Jahr Veränderung | 24.79% |
| 3 Jahre Veränderung | 23.30% |
| 5 Jahre Veränderung | 128.61% |
| Veränderung seit IPO | 662.59% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jun 16
NEOGEN: Preferential Share Issue Will Keep Future P E Excessively Elevated
Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,455, citing relatively unchanged assumptions around revenue growth, profit margins and future P/E multiples, along with a slightly lower discount rate that fine tunes but does not materially shift their overall price target view. What’s in the News for Neogen Chemicals A board meeting is scheduled on May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend recommendation for approval at the 37th AGM.Narrativ-Update • Jun 02
NEOGEN: Preferential Equity Issue Will Sustain Pressure On Elevated Future P E
Analysts have raised their price target on Neogen Chemicals from ₹1,335 to ₹1,455, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider recommending a final dividend on equity shares, subject to shareholder approval at the 37th AGM.Analyseartikel • May 24
Neogen Chemicals' (NSE:NEOGEN) Problems Go Beyond Weak Profit
The market wasn't impressed with the soft earnings from Neogen Chemicals Limited ( NSE:NEOGEN ) recently. We did some...Recent updates
Narrativ-Update • Jun 16
NEOGEN: Preferential Share Issue Will Keep Future P E Excessively Elevated
Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,455, citing relatively unchanged assumptions around revenue growth, profit margins and future P/E multiples, along with a slightly lower discount rate that fine tunes but does not materially shift their overall price target view. What’s in the News for Neogen Chemicals A board meeting is scheduled on May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend recommendation for approval at the 37th AGM.Narrativ-Update • Jun 02
NEOGEN: Preferential Equity Issue Will Sustain Pressure On Elevated Future P E
Analysts have raised their price target on Neogen Chemicals from ₹1,335 to ₹1,455, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E expectations. What's in the News Board meeting scheduled for May 16, 2026 to consider audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider recommending a final dividend on equity shares, subject to shareholder approval at the 37th AGM.Analyseartikel • May 24
Neogen Chemicals' (NSE:NEOGEN) Problems Go Beyond Weak Profit
The market wasn't impressed with the soft earnings from Neogen Chemicals Limited ( NSE:NEOGEN ) recently. We did some...
Narrativ-Update • May 11
NEOGEN: Preferential Equity Funding Will Support Long Term Upside Potential
Analysts have trimmed their price target for Neogen Chemicals from ₹2,630 to about ₹2,311 as they factor in more moderate revenue growth assumptions, a slightly higher profit margin outlook, and a lower future P/E multiple in their models. What's in the News Board meeting scheduled for April 18, 2026, to consider allotment of 1,000,000 equity shares with face value of ₹10 at an issue price of ₹1,610 per share on a preferential basis, aggregating up to ₹1,610,000,000.Narrativ-Update • Apr 23
NEOGEN: Equity Fundraising Plans Will Pressure Elevated Future P E Multiple
Analysts have kept their price target for Neogen Chemicals steady at ₹1,335, citing only small refinements to their discount rate, revenue growth outlook and profit margin assumptions, along with a slightly lower future P/E multiple, rather than any major shift in the investment case. What's in the News On February 11, 2026, the board met to review unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, and to evaluate various options for raising funds through equity and other securities in one or more tranches (company filing).Narrativ-Update • Apr 09
NEOGEN: Future PE Reset Will Test Sustainability Of Recent Cost Improvements
Narrative Update Analysts have held the fair value estimate for Neogen Chemicals steady at ₹1,335.00 while updating assumptions on growth, margins and future P/E. This reflects recent research that cites stronger revenue and EBITDA performance, cost actions taking hold and higher external price targets in the range of roughly ₹540 to ₹1,000 equivalent.
Narrativ-Update • Mar 25
NEOGEN: Raised Guidance And Cost Actions Will Support Higher Future Earnings Quality
Narrative Update Overview The revised analyst price target for Neogen Chemicals edges slightly lower to ₹1,756.25 from ₹1,769.57. This reflects updated assumptions around the discount rate, revenue growth, profit margin, and future P/E, while staying broadly aligned with recent Street research that has cited better revenue and EBITDA prints, higher guidance, and early benefits from cost actions.Narrativ-Update • Mar 10
NEOGEN: Future P E Compression Will Challenge Optimism Around Cost Driven Margin Gains
Our updated fair value estimate for Neogen Chemicals shifts to ₹1,335 from ₹1,670 as analysts factor in slightly adjusted growth assumptions, a modestly lower discount rate, firmer profit margins and a reduced future P/E multiple, broadly in line with recent Street research that links higher targets in other names to improving revenue quality, cost actions and guidance. Analyst Commentary Street research around Neogen Chemicals points to a more measured setup, even as some peers in the sector see higher optimism baked into targets.Narrativ-Update • Feb 24
NEOGEN: Raised Guidance And Cost Actions Will Support Richer Future Earnings Multiple
Analysts have trimmed their fair value estimate for Neogen Chemicals from ₹1,847 to about ₹1,770, as slightly softer revenue growth and margin inputs are being offset by a higher assumed future P/E multiple and recent Street target hikes following better than expected earnings and guidance. Analyst Commentary Recent Street research around Neogen Chemicals reflects a mix of optimism about execution and some caution on how durable the current momentum might be for earnings and valuation.Narrativ-Update • Feb 10
NEOGEN: Raised Guidance And Cost Actions Will Support Further Upside
Narrative Update: Neogen Chemicals Analysts have lifted their price target on Neogen Chemicals to a range of about $10 to $12, up from $6.50 to $8. This change is attributed to the company’s recent revenue and EBITDA beat, raised guidance, and early benefits from portfolio execution and cost actions.Narrativ-Update • Jan 26
NEOGEN: Raised Guidance And Upcoming Board Results Will Support Upside
Narrative Update The analyst price target for Neogen Chemicals has been adjusted from approximately ₹1,812 to ₹1,847 as analysts factor in recent research that points to steady fair value assumptions, a slightly higher discount rate, unchanged growth and margin inputs, and a modestly higher future P/E multiple in light of recent earnings commentary and guidance updates on Neogen. Analyst Commentary Recent Street research on Neogen Chemicals highlights a mix of optimism around execution and guidance, paired with some restraint on how far the valuation should stretch after the latest earnings release.Narrativ-Update • Jan 09
NEOGEN: Steady Fair Value And Upcoming Results Will Support Upside
Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,812.29 per share, with only marginal adjustments to the discount rate, revenue growth, profit margin and future P/E inputs that are too small to materially change the target at this time. What's in the News Board meeting scheduled for November 8, 2025, at 14:30 Indian Standard Time to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).Narrativ-Update • Dec 26
NEOGEN: Market Perform Initiation Will Support Upside From Resilient Margins
Analysts have modestly revised their price target on Neogen Chemicals upward to $10, reflecting slightly higher long term growth expectations and largely stable margin and valuation assumptions. Analyst Commentary The latest initiation at a Market Perform rating with a $10 price target highlights a balanced view on Neogen Chemicals, with analysts seeing the current valuation as broadly aligned with its near to medium term growth prospects.Narrativ-Update • Dec 11
NEOGEN: Market Perform Initiation Will Support Steady Future Return Potential
Analysts have nudged their price target for Neogen Chemicals slightly higher, reflecting a modest improvement in fair value to roughly ₹1,812 per share. This is supported by expectations of sustained high revenue growth and stable valuation multiples, despite only minor adjustments to discount rate and profit margin assumptions.Analyseartikel • Dec 04
Why We're Not Concerned Yet About Neogen Chemicals Limited's (NSE:NEOGEN) 26% Share Price Plunge
The Neogen Chemicals Limited ( NSE:NEOGEN ) share price has fared very poorly over the last month, falling by a...Narrativ-Update • Nov 27
NEOGEN: Broader Customer Base And Joint Venture Will Support Steady Future Returns
Analysts have maintained Neogen Chemicals' price target at $1,806.57, citing stable growth expectations and aligning their assessment with the recent initiation of a Market Perform rating by the Street. Analyst Commentary Bullish Takeaways Bullish analysts note Neogen Chemicals' consistent revenue growth, which supports the current valuation and underpins the stable price target.Analyseartikel • Nov 16
We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
Neogen Chemicals Limited's ( NSE:NEOGEN ) earnings announcement last week contained some soft numbers, disappointing...Analyseartikel • Nov 14
Analysts Are More Bearish On Neogen Chemicals Limited (NSE:NEOGEN) Than They Used To Be
One thing we could say about the analysts on Neogen Chemicals Limited ( NSE:NEOGEN ) - they aren't optimistic, having...Narrativ-Update • Nov 12
NEOGEN: Product Diversification Will Drive Long-Term Returns After New Joint Venture
Analysts have revised Neogen Chemicals' fair value target downward from ₹2,062.83 to ₹1,806.57. This adjustment is due to a slightly higher discount rate and moderated revenue growth expectations, as reflected in recent research updates.Analyseartikel • Nov 11
These 4 Measures Indicate That Neogen Chemicals (NSE:NEOGEN) Is Using Debt Extensively
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Narrativ-Update • Aug 06
Expanding Lithium Battery Materials Will Secure Global Reach
Despite an upward revision in revenue growth forecasts, Neogen Chemicals’ consensus price target has been lowered to ₹2,062, primarily due to a substantial decline in its future P/E multiple. What's in the News Annual dividend decreased to INR 1 per share for FY 2024-25.
Neues Narrativ • Mar 15
Merger With BuLi Chemicals Will Strengthen Market Position In Pharma And Agrochemicals
The merger and strategic product expansions aim to strengthen Neogen's market position and boost future export and domestic revenue growth.Analyseartikel • Feb 21
Neogen Chemicals Limited's (NSE:NEOGEN) P/S Is On The Mark
When you see that almost half of the companies in the Chemicals industry in India have price-to-sales ratios (or "P/S...Analyseartikel • Feb 06
Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models
It's been a pretty great week for Neogen Chemicals Limited ( NSE:NEOGEN ) shareholders, with its shares surging 16% to...Analyseartikel • Dec 26
Here's Why Neogen Chemicals (NSE:NEOGEN) Has A Meaningful Debt Burden
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Dec 10
The Returns On Capital At Neogen Chemicals (NSE:NEOGEN) Don't Inspire Confidence
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Analyseartikel • Nov 20
Why Neogen Chemicals' (NSE:NEOGEN) Shaky Earnings Are Just The Beginning Of Its Problems
A lackluster earnings announcement from Neogen Chemicals Limited ( NSE:NEOGEN ) last week didn't sink the stock price...Analyseartikel • Nov 16
Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
Last week, you might have seen that Neogen Chemicals Limited ( NSE:NEOGEN ) released its second-quarter result to the...Analyseartikel • Sep 20
Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%
The Neogen Chemicals Limited ( NSE:NEOGEN ) share price has done very well over the last month, posting an excellent...Analyseartikel • May 08
We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
Neogen Chemicals Limited's ( NSE:NEOGEN ) recent weak earnings report didn't cause a big stock movement. We think that...Analyseartikel • May 05
Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
As you might know, Neogen Chemicals Limited ( NSE:NEOGEN ) last week released its latest full-year, and things did not...Analyseartikel • Apr 26
After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Neogen Chemicals Limited ( NSE:NEOGEN ) shares have had a really impressive month, gaining 27% after a shaky period...Analyseartikel • Apr 12
Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Neogen Chemicals fair value estimate is ₹1,238 Current share...Aktionärsrenditen
| NEOGEN | IN Chemicals | IN Markt | |
|---|---|---|---|
| 7D | 6.8% | 1.9% | 1.0% |
| 1Y | 24.8% | -4.6% | -1.4% |
Rendite im Vergleich zur Industrie: NEOGEN übertraf die Branche Indian Chemicals , die im vergangenen Jahr eine Rendite von -4.6 erzielte.
Rendite vs. Markt: NEOGEN übertraf den Markt Indian, der im vergangenen Jahr eine Rendite von -1.4 erzielte.
Preisvolatilität
| NEOGEN volatility | |
|---|---|
| NEOGEN Average Weekly Movement | 7.1% |
| Chemicals Industry Average Movement | 6.3% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.1% |
Stabiler Aktienkurs: NEOGEN hatte in den letzten 3 Monaten im Vergleich zum Indian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: NEOGENDie wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1989 | 779 | Harin Kanani | www.neogenchem.com |
Neogen Chemicals Limited beschäftigt sich mit der Herstellung und dem Verkauf von Spezialchemikalien in Indien. Das Unternehmen bietet bromorganische Verbindungen wie Alkylbromidverbindungen, Dibromalkanverbindungen, Bromchloralkane, Bromderivate von Organosäuren, Bromsäureesterverbindungen, aromatische Bromderivate, zyklische Bromderivate und spezielle Bromfluorderivate an; spezielle Chlorverbindungen, ungesättigte Bromderivate, Bromhydroxyderivate und andere Verbindungen sowie Organolithiumverbindungen, einschließlich n-Butyllithium, Lithiumhexamethyldisilazid, Lithiumtetrahydridborat, Lithiumdiisopropylamid, Lithiumtri-(t-butoxy)-Aluminiumhydrid, Hexyllithium, Methyllithium und Phenyllithium. Das Unternehmen bietet auch anorganische Chemikalien an, darunter anorganische Bromverbindungen und Lithiumsalze, Grignard-Reagenzien und Zwischenprodukte sowie chemische Verfahren wie Alkylierung, Acylierung, Aminatinierung, Oxidation, Dehalogenierung, Silylierung, Halex-Reaktion, Friedel-Handwerk, Kupplungen und Chlorierung, Auftragssynthese und Auftragsfertigung.
Neogen Chemicals Limited's Grundlagenzusammenfassung
| NEOGEN grundlegende Statistiken | |
|---|---|
| Marktanteil | ₹55.03b |
| Gewinn(TTM) | ₹287.50m |
| Umsatz(TTM) | ₹8.62b |
191.4x
Kurs-Gewinn-Verhältnis 6.4x
Kurs-Umsatz-VerhältnisIst NEOGEN zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| NEOGEN Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | ₹8.62b |
| Kosten der Einnahmen | ₹4.66b |
| Bruttogewinn | ₹3.96b |
| Sonstige Ausgaben | ₹3.67b |
| Gewinn | ₹287.50m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 10.50 |
| Bruttomarge | 45.89% |
| Nettogewinnspanne | 3.34% |
| Schulden/Eigenkapital-Verhältnis | 162.9% |
Wie hat sich NEOGEN auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
0.05%
Aktuelle Dividendenrendite9%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/06 16:59 |
| Aktienkurs zum Tagesende | 2026/07/06 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2026/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Neogen Chemicals Limited wird von 16 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| null null | Asian Markets Securities Private Limited |
| Vijayaraghavan Swaminathan | Avendus Spark |